Omics approaches to discover pathophysiological pathways contributing to human pain

L Diatchenko, M Parisien, SJ Esfahani, JS Mogil - Pain, 2022 - journals.lww.com
There exist limited data to inform mechanism-based understanding and management of
chronic pain, and thus, there is a clear unmet need to better define the molecular …

The concept of nociplastic pain—where to from here?

E Kosek - Pain, 2024 - journals.lww.com
Nociplastic pain, a third mechanistic pain descriptor in addition to nociceptive and
neuropathic pain, was adopted in 2017 by the International Association for the Study of Pain …

[HTML][HTML] Fibromyalgia patients with elevated levels of anti–satellite glia cell immunoglobulin G antibodies present with more severe symptoms

E Krock, CE Morado-Urbina, J Menezes, MA Hunt… - Pain, 2023 - journals.lww.com
Transferring fibromyalgia patient immunoglobulin G (IgG) to mice induces pain-like
behaviour, and fibromyalgia IgG binds mouse and human satellite glia cells (SGCs). These …

A Comprehensive review of the genetic and epigenetic contributions to the development of fibromyalgia

EA Ovrom, KA Mostert, S Khakhkhar, DP McKee… - Biomedicines, 2023 - mdpi.com
This narrative review summarizes the current knowledge of the genetic and epigenetic
contributions to the development of fibromyalgia (FM). Although there is no single gene that …

The therapeutic potential of natural killer cells in neuropathic pain

HW Kim, S Wang, AJ Davies, SB Oh - Trends in Neurosciences, 2023 - cell.com
Novel disease-modifying treatments for neuropathic pain are urgently required. The cellular
immune response to nerve injury represents a promising target for therapeutic development …

Long COVID and the neuroendocrinology of microbial translocation outside the GI tract: some treatment strategies

A Sfera, C Osorio, S Hazan, Z Kozlakidis… - Endocrines, 2022 - mdpi.com
Similar to previous pandemics, COVID-19 has been succeeded by well-documented post-
infectious sequelae, including chronic fatigue, cough, shortness of breath, myalgia, and …

miR-374 family is a key regulator of chronic primary pain onset

NP Hernandez, A Rawls, J Chen, X Zhang, Y Wang… - Pain …, 2024 - journals.lww.com
Objectives: We sought to identify RNA species correlated with case status in 3 pain cohorts,
to validate RNAs found to be dysregulated in a mouse model of CPPC onset, and to directly …

Finding new analgesics: Computational pharmacology faces drug discovery challenges

A Barakat, G Munro, AM Heegaard - Biochemical pharmacology, 2024 - Elsevier
Despite the worldwide prevalence and huge burden of pain, pain is an undertreated
phenomenon. Currently used analgesics have several limitations regarding their efficacy …

Distinct CholinomiR blood cell signature as a potential modulator of the cholinergic system in women with fibromyalgia syndrome

C Erbacher, S Vaknine, G Moshitzky, S Lobentanzer… - Cells, 2022 - mdpi.com
Fibromyalgia syndrome (FMS) is a heterogeneous chronic pain syndrome characterized by
musculoskeletal pain and other key co-morbidities including fatigue and a depressed mood …

A systematic literature review on the clinical efficacy of low dose naltrexone and its effect on putative pathophysiological mechanisms among patients diagnosed with …

S Partridge, L Quadt, M Bolton, J Eccles, C Thompson… - Heliyon, 2023 - cell.com
Background Low dose naltrexone (LDN) is used off-label by many individuals with
fibromyalgia to help manage their pain. There is no current systematic literature review …